Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial
| Image |  |
|---|---|
| Description | scientific article published on 27 November 2019 |
| Author/s |
author: Hope Rugo Amreen Husain Sherene Loi Sylvia Adams Hiroji Iwata Eric Winer |
| Publication date | November 27, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |